Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Copelan

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Journal of Clinical Apheresis|June 8, 2011
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yieldHien K Duong, Brian J Bolwell, Lisa Rybicki, et al.
Journal of Clinical Apheresis|November 15, 2017
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection daysJack Khouri, Lisa Rybicki, Navneet Majhail, et al.
Experimental Hematology|May 14, 2024
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapyDavid M Foureau, Fei Guo, Nury M Steuerwald, et al.
American Journal of Hematology|October 30, 2014
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantationBetty K Hamilton, Lisa Rybicki, Robert Dean, et al.
American Journal of Hematology|June 26, 2012
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemiaDi Sun, Paul Elson, Michaela Liedtke, et al.
British Journal of Haematology|March 18, 2011
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centresStephen D Smith, Craig H Moskowitz, Robert Dean, et al.
The Pharmacogenomics Journal|November 5, 2023
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosingJai N Patel, Myra Robinson, Sarah A Morris, et al.
JCO Oncology Practice|November 18, 2024
Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical PracticeNilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose, et al.
Pharmacogenomics|October 17, 2023
Evaluation of pentamidine tolerability and efficacy between <i>CYP2C19</i> phenotypesAlexis Koon, Jiaxian He, Jai Patel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2013
Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeJoshua Lukenbill, Lisa Rybicki, Mikkael A Sekeres, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Journal of Clinical Apheresis|June 8, 2011
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yieldHien K Duong, Brian J Bolwell, Lisa Rybicki, et al.
Journal of Clinical Apheresis|November 15, 2017
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection daysJack Khouri, Lisa Rybicki, Navneet Majhail, et al.
Experimental Hematology|May 14, 2024
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapyDavid M Foureau, Fei Guo, Nury M Steuerwald, et al.
American Journal of Hematology|October 30, 2014
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantationBetty K Hamilton, Lisa Rybicki, Robert Dean, et al.
American Journal of Hematology|June 26, 2012
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemiaDi Sun, Paul Elson, Michaela Liedtke, et al.
British Journal of Haematology|March 18, 2011
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centresStephen D Smith, Craig H Moskowitz, Robert Dean, et al.
The Pharmacogenomics Journal|November 5, 2023
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosingJai N Patel, Myra Robinson, Sarah A Morris, et al.
JCO Oncology Practice|November 18, 2024
Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical PracticeNilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose, et al.
Pharmacogenomics|October 17, 2023
Evaluation of pentamidine tolerability and efficacy between <i>CYP2C19</i> phenotypesAlexis Koon, Jiaxian He, Jai Patel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2013
Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndromeJoshua Lukenbill, Lisa Rybicki, Mikkael A Sekeres, et al.
Pageof 9